Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom Street
Boston, MA 02114Phone+1 617-724-1159Fax+1 617-726-3603
Education & Training
- University of MichiganResidency, Radiation Oncology, 2004 - 2009
- University of MichiganInternship, Internal Medicine, 2004 - 2005
- University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
- MA State Medical License 2009 - 2025
- NH State Medical License 2011 - 2025
- ME State Medical License 2020 - 2021
- MI State Medical License 2004 - 2009
- American Board of Radiology Radiation Oncology
Clinical Trials
- MET-PET for Newly Diagnosed Glioblastoma Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- Survival in Patients With Spinal Metastatic Disease Treated Nonoperatively With Radiotherapy: Are the SORG-ML Algorithms Relevant?Brian P Fenn, Aditya V Karhade, Olivier Q Groot, Austin K Collins, Tracy A Balboni
Clinical Spine Surgery. 2024-08-01 - Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.Albert E Kim, Kevin W Lou, Anita Giobbie-Hurder, Ken Chang, Mishka Gidwani
Neuro-Oncology. 2024-05-03 - 16 citationsPembrolizumab in brain metastases of diverse histologies: phase 2 trial results.Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Q Lee, Nancy U Lin
Nature Medicine. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: